Journal profile · Obstetrics & Gynecology
Contraception
ISSN 0010-7824 · eISSN 1879-0518 · Elsevier USA · UNITED STATES · Monthly · Founded 1970
Contraception: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 2.35; hybrid open access; APC about USD 3,500; median 134 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly easy; 361 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Contraception is published by Elsevier USA and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Reproductive Health and Contraception, Global Maternal and Child Health and Maternal and Perinatal Health Interventions, together about 45% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
An international reproductive health journal The Official Journal of the Society of Family PlanningThe journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new global scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education from all parts of the world.
From the journal's Aims & Scope
Research area (LetPub): Obstetrics & Gynecology
Editorial board by country: none in mainland China; most named United States 48, Canada 4, Brazil 3 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Reproductive Health and ContraceptionMedicine31.4%
- Global Maternal and Child HealthMedicine8%
- Maternal and Perinatal Health InterventionsMedicine5.5%
- Reproductive Health and TechnologiesMedicine5.3%
- Ovarian function and disordersMedicine4.8%
- Adolescent Sexual and Reproductive HealthHealth Professions4.1%
- Maternal and fetal healthcareMedicine3.8%
- Reproductive System and PregnancyImmunology and Microbiology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Obstetrics & Gynecology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Obstetrics & Gynecology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Obstetrics & Gynecology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.35LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- SJR 2026-06
- 0.93LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 92LetPub ·
- h-index
- 147OpenAlex ·
- i10-index
- 5,165OpenAlex ·
- 2-year mean citedness
- 1.32OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 18.14%LetPub ·
Volume
- Articles per year
- 149LetPub ·
Articles by year OpenAlex count · 12,728 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 126 | 54 | 24 |
| 2025 | 361 | 135 | 374 |
| 2024 | 325 | 98 | 672 |
| 2023 | 338 | 115 | 1,371 |
| 2022 | 313 | 104 | 1,517 |
| 2021 | 348 | 213 | 3,369 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
134 daysMedian, submission to acceptance · P25–P75 105 days – 180 days
- Acceptance to online
- median 4 days (98 articles)
- Submission to online
- median 138 days
- Sample
- 98 articles with submission and acceptance dates (398 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 47 daysPublisher website ·
- Submission to acceptance
- 128 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,500 / EUR 3,270 / GBP 2,800 / JPY 434,110 | — | — | |
| Publisher website | USD 3,540 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 2,500 words
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted10, with length limits
- brief research articleBrief Research Articles are scientific reports of original research that represent preliminary findings, small samples and newly described associations in uniqu…Length not stated
- case reportsOnly Case Reports that are highly original, have significant implications for clinical practice, and/or provide information that will lead to important future r…Length not stated
- letterOriginal Research ArticleOriginal Research Articles should not exceed 2500 words of text (not including the title, title page, abstract, acknowledgements, refer…Length not stated
- letter to the editorLetters to the Editor are openly solicited. The Journal supports Letters as a forum to convey comments and opinions regarding recently published articles.Length not stated
- original researchOriginal Research ArticleOriginal Research Articles should not exceed 2500 words of text (not including the title, title page, abstract, acknowledgements, refer…Length not stated
- original research articleOriginal Research ArticleOriginal Research Articles should not exceed 2500 words of text (not including the title, title page, abstract, acknowledgements, refer…main text ≤ 1,000 words
- research articleOriginal Research ArticleOriginal Research Articles should not exceed 2500 words of text (not including the title, title page, abstract, acknowledgements, refer…Length not stated
- reviewOriginal Research ArticleOriginal Research Articles should not exceed 2500 words of text (not including the title, title page, abstract, acknowledgements, refer…main text ≤ 5,000 words
- review articleReviews are generally by invitation. Contraception publishes systematic reviews that adhere to PRISMA (https://www.prisma-statement.org/) guidelines.Length not stated
- systematic reviewOriginal Research ArticleOriginal Research Articles should not exceed 2500 words of text (not including the title, title page, abstract, acknowledgements, refer…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
1 to 7 keywords required Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier USA
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1970
- ISSN
- 0010-7824
- Electronic ISSN
- 1879-0518
- Society / sponsor
- Society of Family Planning
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Contraception
What CAS zone is Contraception in?
In the 2025 upgraded edition of the CAS Journal Ranking, Contraception is in Zone 2 of Medicine, and in Zone 2 of the minor category Obstetrics & Gynecology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Contraception?
The latest impact factor listed by LetPub is 2.35; CiteScore 4.1, h-index 147.
How long does peer review take at Contraception?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 134 days (interquartile range 105–180 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Contraception?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 2,500 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Contraception based?
Of the 55 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (48), Canada (4) and Brazil (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Contraception?
According to LetPub and DOAJ records, Contraception is indexed in SCIE and Scopus.
Is Contraception open access, and what is the APC?
Contraception is a hybrid journal. For open-access publication: APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .